View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financ...

OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces financial guidance for the first quarter and full year 2026. Highlights from the fourth quarter of 2025 and recent weeks include the following: Entered into a research collaboration with Regeneron Pharmaceuticals to develop multispecific antibodies. This n...

 PRESS RELEASE

Altisource Portfolio Solutions S.A. Schedules Fourth Quarter 2025 Conf...

Altisource Portfolio Solutions S.A. Schedules Fourth Quarter 2025 Conference Call LUXEMBOURG, Feb. 19, 2026 (GLOBE NEWSWIRE) -- On Wednesday, March 4, 2026, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ: ASPS) will report earnings for the fourth quarter 2025. A press release and presentation will be available on Altisource’s website in the Investor Relations section. Altisource will also host a conference call at 8:30 a.m. EST on the same day to discuss its fourth quarter 2025 results. A link to the live audio webcast will be available on Altisource’s website in the Investor...

 PRESS RELEASE

Altisource Names Rick Seehausen President of Lenders One

Altisource Names Rick Seehausen President of Lenders One Industry veteran to lead Altisource’s Origination segment and help shape the Company’s strategic growth LUXEMBOURG, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource®” or the “Company”) (NASDAQ: ASPS), a leading provider of real estate and mortgage solutions, today announced the appointment of Rick Seehausen as President of Lenders One®. In this role, Mr. Seehausen will lead the strategic direction and day-to-day operations of Altisource’s Origination segment, including the delivery of Altisource’...

 PRESS RELEASE

OPKO Health to Report Fourth Quarter 2025 Financial Results on Februar...

OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on Thursday, February 26, 2026. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-r...

 PRESS RELEASE

Statebridge Company Selects Equator® to Support Growing REO Asset Mana...

Statebridge Company Selects Equator® to Support Growing REO Asset Management Operations Mortgage servicer adopts Equator to manage residential & business purpose REO inventory. LUXEMBOURG, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Equator®, an Altisource® (NASDAQ: ASPS) business unit and a leading SaaS platform for residential real estate management, today announced that Statebridge Company, a mortgage servicer specializing in non-agency, GSE portfolios and Business Purpose loans, has selected Equator as its platform to manage REO operations. Equator powers end‑to‑end residential asset managem...

 PRESS RELEASE

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Clas...

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilities The companies have accelerated this program and aim to file an investigational new drug (IND) application in late 2026 Injectable and oral oxyntomodulin (dual GLP-1/glucagon analog) for metabolic and fibrotic disorders advancing with initial Phase 1 data from injectable oxyntomodulin (OXM) expected in late 2026; o...

Incyte Corp: 1 director

A director at Incyte Corp sold 10,856 shares at 109.070USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

 PRESS RELEASE

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare C...

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 44th Annual J.P. Morgan Healthcare Conference, being held January 12-15, 2026, at the Westin St. Francis Hotel in San Francisco.  Management will be hosting one-on-one meetings with investors and will be participating in a fireside chat on Wednesday, January 14th at 1:30 p.m. Pacific time. The fireside chat will be webcast live and available for replay in the Investors sectio...

 PRESS RELEASE

Lenders One Reports Strong Sales Momentum in Origination Solutions

Lenders One Reports Strong Sales Momentum in Origination Solutions Estimated $15 Million in Annual Closed-Won Contracts and Expanding Late-Stage Pipeline with over 39 Prospects LUXEMBOURG, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource®” or the “Company”) (NASDAQ: ASPS), a leading provider of real estate and mortgage solutions, today announced significant sales momentum in its Origination Solutions business, driven by strong demand for Lenders One® Credit (“L1 Credit”) and Lenders One® Verification (“L1 Verification”) services. The Company recently si...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: December 13, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

International Flavors & Fragrances Inc: 1 director

A director at International Flavors & Fragrances Inc bought 3,100 shares at 63.480USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: December 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Opko Health Inc: 1 director

A director at Opko Health Inc bought 580,000 shares at 1.326USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch